Open AccessCA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study
Author(s) -
Benoît You,
Vasudha Sehgal,
Balakrishna Hosmane,
Xin Huang,
Peter Ansell,
Minh H. Dinh,
Katherine M. BellMcGuinn,
Xizhi Luo,
Gini F. Fleming,
Michael Friedlander,
Michael A. Bookman,
Kathleen N. Moore,
Karina Dahl Steffensen,
Robert L. Coleman,
Elizabeth M. Swisher
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.22.00430
Subject(s) - veliparib , medicine , carboplatin , hazard ratio , debulking , oncology , ovarian cancer , confidence interval , cancer , surgery , urology , chemotherapy , poly adp ribose polymerase , cisplatin , biology , polymerase , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom